264 related articles for article (PubMed ID: 23604483)
1. Cancer chronotherapeutics: experimental, theoretical, and clinical aspects.
Ortiz-Tudela E; Mteyrek A; Ballesta A; Innominato PF; Lévi F
Handb Exp Pharmacol; 2013; (217):261-88. PubMed ID: 23604483
[TBL] [Abstract][Full Text] [Related]
2. Circadian timing in cancer treatments.
Lévi F; Okyar A; Dulong S; Innominato PF; Clairambault J
Annu Rev Pharmacol Toxicol; 2010; 50():377-421. PubMed ID: 20055686
[TBL] [Abstract][Full Text] [Related]
3. Implications of circadian clocks for the rhythmic delivery of cancer therapeutics.
Lévi F; Focan C; Karaboué A; de la Valette V; Focan-Henrard D; Baron B; Kreutz F; Giacchetti S
Adv Drug Deliv Rev; 2007 Aug; 59(9-10):1015-35. PubMed ID: 17692427
[TBL] [Abstract][Full Text] [Related]
4. [The circadian-timing system: a determinant of drug activity and a target of anticancer treatments].
Lévi F
Ann Pharm Fr; 2008 Jun; 66(3):175-84. PubMed ID: 18706346
[TBL] [Abstract][Full Text] [Related]
5. Identification of Circadian Determinants of Cancer Chronotherapy through In Vitro Chronopharmacology and Mathematical Modeling.
Dulong S; Ballesta A; Okyar A; Lévi F
Mol Cancer Ther; 2015 Sep; 14(9):2154-64. PubMed ID: 26141947
[TBL] [Abstract][Full Text] [Related]
6. The circadian timing system in clinical oncology.
Innominato PF; Roche VP; Palesh OG; Ulusakarya A; Spiegel D; Lévi FA
Ann Med; 2014 Jun; 46(4):191-207. PubMed ID: 24915535
[TBL] [Abstract][Full Text] [Related]
7. [Chronopharmacology and chronotherapy of cancers].
Lévi F
Pathol Biol (Paris); 1996 Sep; 44(7):631-44. PubMed ID: 8977920
[TBL] [Abstract][Full Text] [Related]
8. Circadian clocks and drug delivery systems: impact and opportunities in chronotherapeutics.
Lévi F; Okyar A
Expert Opin Drug Deliv; 2011 Dec; 8(12):1535-41. PubMed ID: 22097903
[TBL] [Abstract][Full Text] [Related]
9. Chronotherapeutics: the relevance of timing in cancer therapy.
Lévi F
Cancer Causes Control; 2006 May; 17(4):611-21. PubMed ID: 16596317
[TBL] [Abstract][Full Text] [Related]
10. Implications of circadian clocks for the rhythmic delivery of cancer therapeutics.
Lévi F; Altinok A; Clairambault J; Goldbeter A
Philos Trans A Math Phys Eng Sci; 2008 Oct; 366(1880):3575-98. PubMed ID: 18644767
[TBL] [Abstract][Full Text] [Related]
11. Systems Chronotherapeutics.
Ballesta A; Innominato PF; Dallmann R; Rand DA; Lévi FA
Pharmacol Rev; 2017 Apr; 69(2):161-199. PubMed ID: 28351863
[TBL] [Abstract][Full Text] [Related]
12. Identifying mechanisms of chronotolerance and chronoefficacy for the anticancer drugs 5-fluorouracil and oxaliplatin by computational modeling.
Altinok A; Lévi F; Goldbeter A
Eur J Pharm Sci; 2009 Jan; 36(1):20-38. PubMed ID: 19041394
[TBL] [Abstract][Full Text] [Related]
13. Cross-talks between circadian timing system and cell division cycle determine cancer biology and therapeutics.
Lévi F; Filipski E; Iurisci I; Li XM; Innominato P
Cold Spring Harb Symp Quant Biol; 2007; 72():465-75. PubMed ID: 18419306
[TBL] [Abstract][Full Text] [Related]
14. Chronotherapy and the molecular clock: Clinical implications in oncology.
Innominato PF; Lévi FA; Bjarnason GA
Adv Drug Deliv Rev; 2010 Jul; 62(9-10):979-1001. PubMed ID: 20600409
[TBL] [Abstract][Full Text] [Related]
15. Molecular Aspects of Circadian Pharmacology and Relevance for Cancer Chronotherapy.
Ozturk N; Ozturk D; Kavakli IH; Okyar A
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29039812
[TBL] [Abstract][Full Text] [Related]
16. [Chronobiology and cancer].
Lévi F
Pathol Biol (Paris); 1987 Jun; 35(6):960-8. PubMed ID: 3306577
[TBL] [Abstract][Full Text] [Related]
17. A cell cycle automaton model for probing circadian patterns of anticancer drug delivery.
Altinok A; Lévi F; Goldbeter A
Adv Drug Deliv Rev; 2007 Aug; 59(9-10):1036-53. PubMed ID: 17692993
[TBL] [Abstract][Full Text] [Related]
18. From circadian rhythms to cancer chronotherapeutics.
Lévi F
Chronobiol Int; 2002 Jan; 19(1):1-19. PubMed ID: 11962669
[TBL] [Abstract][Full Text] [Related]
19. Cancer chronotherapy: a drug delivery challenge.
Hrushesky WJ
Prog Clin Biol Res; 1990; 341A():1-10. PubMed ID: 2145583
[TBL] [Abstract][Full Text] [Related]
20. The circadian timing system, a coordinator of life processes. implications for the rhythmic delivery of cancer therapeutics.
Lévi F
Conf Proc IEEE Eng Med Biol Soc; 2006; Suppl():6736-9. PubMed ID: 17959499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
